J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer Post author:Sam Post published:February 14, 2018 Post category:BioPharma Janssen got a little love from the FDA on Wednesday. Source: BioSpace You Might Also Like FDA Gives Nod to Johnson & Johnson's Potential Blockbuster Psoriasis Med July 13, 2017 Sanofi Abandons Multiple Mid-Stage Drug Programs February 7, 2018 Multiple Myeloma Research Foundation (MMRF) Announces $15 Million Investment In Immunotherapy Initiative June 28, 2017
Multiple Myeloma Research Foundation (MMRF) Announces $15 Million Investment In Immunotherapy Initiative June 28, 2017
